Literature DB >> 7844552

Phospholipid interactions of the putative fusion peptide of hepatitis B virus surface antigen S protein.

I Rodríguez-Crespo1, E Núñez, J Gómez-Gutiérrez, B Yélamos, J P Albar, D L Peterson, F Gavilanes.   

Abstract

One of the first steps in the infective cycle of an enveloped virus consists of the fusion of the viral and cellular membranes. This process is usually achieved as a result of membrane destabilization brought about by a viral fusion peptide located at the amino terminus of one of the viral envelope glycoproteins. Previous sequence similarity studies by Rodríguez-Crespo et al. (Journal of General Virology 75, 637-639, 1994) have shown that a hydrophobic stretch in the amino-terminal sequence of the S protein of hepatitis B virus shares several characteristics with fusion peptides of retroviruses and paramyxoviruses. A 16 residue peptide with this sequence was synthesized and its interaction with liposomes characterized. This peptide was able to mediate vesicle aggregation, lipid mixing and liposome leakage in a pH dependent manner at concentrations ranging from 3.5 to 52.0 microM. These effects were specific for negatively charged phospholipid vesicles. The peptide was also able to haemolyse erythrocytes. This study supports the notion that the sequence might be important in the initial infective steps of this virus, interacting with the target membranes and bringing about their subsequent destabilization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7844552     DOI: 10.1099/0022-1317-76-2-301

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Oligomerization of fusogenic peptides promotes membrane fusion by enhancing membrane destabilization.

Authors:  Wai Leung Lau; David S Ege; James D Lear; Daniel A Hammer; William F DeGrado
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

3.  A soluble peripherin/Rds C-terminal polypeptide promotes membrane fusion and changes conformation upon membrane association.

Authors:  Kathleen Boesze-Battaglia; Andrew F X Goldberg; Janice Dispoto; Madan Katragadda; Gregory Cesarone; Arlene D Albert
Journal:  Exp Eye Res       Date:  2003-10       Impact factor: 3.467

4.  A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity.

Authors:  Gretchen E Nelson; Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

5.  Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.

Authors:  Matthieu Blanchet; Camille Sureau
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  A hydrophobic domain in the large envelope protein is essential for fusion of duck hepatitis B virus at the late endosome.

Authors:  J Chojnacki; D A Anderson; E V L Grgacic
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  A metastable form of the large envelope protein of duck hepatitis B virus: low-pH release results in a transition to a hydrophobic, potentially fusogenic conformation.

Authors:  E V Grgacic; H Schaller
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression.

Authors:  L Maresova; T J Pasieka; C Grose
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.

Authors:  X Lu; T M Block; W H Gerlich
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  The translocation motif of hepatitis B virus envelope proteins is dispensable for infectivity.

Authors:  Charlotte Lepère; Morgane Régeard; Jacques Le Seyec; Philippe Gripon
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.